Titan Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-7.314; its P/E ratio is -1.00; Titan Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 4.00K	$ 83.00K	$ 98.00K	$ 120.00K	$ 4.00K
Gross Profit	$ 4.00K	$ 83.00K	-	-	$ 4.00K
EBIT	$ -338.00K	$ -1.59M	$ 1.89M	$ -2.59M	$ -2.64M
EBITDA	$ -311.00K	$ -1.55M	$ 1.94M	$ -2.10M	$ -2.60M
Net Income Common Stockholders	$ -338.00K	$ -1.59M	$ 1.92M	$ -2.57M	$ -2.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.10M	$ 105.00K	$ 1.14M	$ 2.94M	$ 4.45M
Total Assets	$ 10.00M	$ 812.00K	$ 2.17M	$ 4.06M	$ 6.28M
Total Debt	$ 97.00K	$ 128.00K	$ 158.00K	$ 187.00K	$ 216.00K
Net Debt	$ -8.00M	$ 23.00K	$ -978.00K	$ -2.75M	$ -4.23M
Total Liabilities	$ 1.87M	$ 1.85M	$ 2.48M	$ 2.69M	$ 2.73M
Stockholders Equity	$ 8.13M	$ -1.03M	$ -312.00K	$ 1.36M	$ 3.55M
Cash Flow	-
Free Cash Flow	$ -1.61M	$ -1.11M	$ -1.90M	$ -1.58M	$ -1.87M
Operating Cash Flow	$ -1.83M	$ -1.11M	$ -1.90M	$ -1.58M	$ -1.87M
Investing Cash Flow	$ 228.00K	-	-	-	$ 0.00
Financing Cash Flow	$ 9.59M	-	-	-	$ 0.00

Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

Income Statement >

Titan Pharmaceuticals Debt to Assets

Balance Sheet >

Titan Pharmaceuticals Cash Flow

Cash Flow >

Titan Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing